- Home
- STRW vs ACHV Comparison
STRW vs ACHV Comparison
Compare STRW & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRW
- ACHV
- Stock Information
- Founded
- STRW 2015
- ACHV N/A
- Country
- STRW United States
- ACHV Canada
- Employees
- STRW N/A
- ACHV N/A
- Industry
- STRW Real Estate Investment Trusts
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- STRW Real Estate
- ACHV Health Care
- Exchange
- STRW Nasdaq
- ACHV Nasdaq
- Market Cap
- STRW 119.6M
- ACHV 126.9M
- IPO Year
- STRW N/A
- ACHV N/A
- Fundamental
- Price
- STRW $11.18
- ACHV $3.09
- Analyst Decision
- STRW Strong Buy
- ACHV Strong Buy
- Analyst Count
- STRW 5
- ACHV 5
- Target Price
- STRW $12.38
- ACHV $14.80
- AVG Volume (30 Days)
- STRW 119.9K
- ACHV 277.4K
- Earning Date
- STRW 11-08-2024
- ACHV 11-07-2024
- Dividend Yield
- STRW 4.65%
- ACHV N/A
- EPS Growth
- STRW 23.40
- ACHV N/A
- EPS
- STRW 0.51
- ACHV N/A
- Revenue
- STRW $112,050,000.00
- ACHV N/A
- Revenue This Year
- STRW N/A
- ACHV N/A
- Revenue Next Year
- STRW $9.02
- ACHV N/A
- P/E Ratio
- STRW $21.97
- ACHV N/A
- Revenue Growth
- STRW 14.46
- ACHV N/A
- 52 Week Low
- STRW $6.56
- ACHV $3.04
- 52 Week High
- STRW $12.90
- ACHV $5.59
- Technical
- Relative Strength Index (RSI)
- STRW 54.67
- ACHV 29.72
- Support Level
- STRW $10.95
- ACHV $3.12
- Resistance Level
- STRW $11.35
- ACHV $3.86
- Average True Range (ATR)
- STRW 0.43
- ACHV 0.21
- MACD
- STRW 0.12
- ACHV -0.03
- Stochastic Oscillator
- STRW 70.47
- ACHV 8.33
About STRW Strawberry Fields REIT Inc.
Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.